Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 105 results for "cipla"

Pharma weekly wrap: Pharma stocks extend loses ahead of Q3 results
Money Control

Pharma weekly wrap: Pharma stocks extend loses ahead of Q3 res...

Most stocks including Sun Pharma (-2.24 percent), Cipla (-1.79 percent), Aurobindo Pharma (-3.98 percent) and Cadila Healthcare (-2.1 percent) saw declines Money Control, 1 day ago

32 images for cipla

Business Standard, 6 days ago
Money Control, 3 weeks ago
Money Today, 1 month ago
Afaqs, 1 month ago
Afaqs, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Business Standard, 2 months ago
Money Control, 1 month ago
Business Standard

Cipla updates on its strategy for operating on B2B model in Europe

Sells 100% stake in Cipla, Croatia to PharmaS, Croatia Cipla announced that Cipla Holdings B.V., a subsidiary of the Company has entered into an agreement to sell its 100% equity stake in Cipla Croatia d.o.o, Croatia to PharmaS d.o.o, Croatia in order to ...
 Business Standard1 month ago Cipla gets WHO nod to sell drug that prevents TB in HIV patients  Business Standard1 month ago Cipla launches Q-TIB globally  Money Control1 month ago FDC jumps 9%, Cipla gains over 1% on UK regulator approval for plants  Money Control2 months ago
Money Control

Market Live: Sensex, Nifty recover after steep opening losses as BJP leads in Himachal, Gujarat

Out of 30 stocks, only 1 stock is trading in green, which is Cipla after getting tentative approval from the US Food and Drug Administration for HIV drug, Darunavir hydrate (75-800 mg).
 Money Control1 month ago Closing Bell: Sensex ends 118 pts higher, Nifty above 10,300; pharma soars  Money Control1 month ago Market Live: Sensex, Nifty volatile ahead of ITC, ICICI Bank earnings  Money Control2 months ago Stock market gains momentum on Day 2 of 2018  Rediff.com2 weeks ago
Business Standard

Pharma weight in BSE to touch 5-year low

With drug makers Lupin and Cipla set to be replaced in the S&P BSE Sensex by IndusInd Bank and YES Bank, the weight of the pharmaceutical industry in the index would decline to a five-year low. The index, jointly owned by the BSE and the US-based S&P, is a ...
 Business Standard2 months ago IndusInd Bank, Yes Bank firm up on Sensex entry  Business Standard2 months ago Yes Bank, IndusInd Bank correct 1-2% on inclusion in BSE Sensex; Cipla, Lupin weak  Money Control2 months ago Stocks in the news: LT, AstraZeneca, Biocon, Lupin, Yes Bank, Divis, Eris, RCom, Voltas  Money Control2 months ago

Stocks in the news: IOB, Orbit Exports, HPCL, GM Breweries, Varun Beverages, NIIT, Hindalco

Indian Overseas Bank | Cipla | Orbit Exports | JSW Energy | Hindalco | Take Solutions | Bajaj Electricals | Varun Beverages | Punjab National Bank | Jaiprakash Associates | NIIT | GTL Infrastructure | Idea Cellular | ICICI Bank | Reliance Communications | ...
 Money Control2 weeks ago
Money Control

Market Update: IT, Realty outperforms; RIL up 1%, United Spirits hits 52-week high; Hindalco dips 3%

Reliance Industries added 1 percent while Tech Mahindra, HCL Tech, Infosys and Cipla were the other top Nifty gainers. The market breadth was in favour of the advances on Wednesday morning with 821 stocks advancing as against 801 declines. On the other hand, ...
 Money Control1 month ago Market Update: Axis Bank top gainer, TCS hits new 52-week high; SBI most active  Money Control2 months ago Cipla hits 52-week high ahead of Q2 results  Business Standard2 months ago Market update: Axis Bank, HCL Tech top Nifty gainers; RComm zooms over 11%  Money Control2 months ago

Cipla Health appoints OMD Mudramax as media agency

The account was won post a multi-agency pitch. Himava Nath In a recent announcement, following a multi-agency pitch, OMD Mudramax has bagged the media duties of Cipla Health Limited. The agency will be partnering with the brands under Cipla Health in their ...
 Afaqs1 month ago
Business Standard

Cipla battles perceptions in a new campaign

Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the ...
 Business Standard1 month ago
Money Control

Market Update: Cipla gains over 3%; Axis Bank hits 52-week high, Bharti Airtel most active

CNX Pharma gained close to 1 percent led by Cipla, Sun Pharma and Aurobindo Pharma while Bharti Airtel, Axis Bank, Lupin, Yes Bank and Reliance Industries were the most active stocks.
 Money Control2 months ago Market update: Bharti Airtel, Cipla hit new 52-week high; ICICI, SBI, Sun Pharma most active  Money Control2 months ago Market Update: CNX Pharma outperforms led by Dr Reddy#39;s , Sun Pharma; RComm zooms over 11%  Money Control2 months ago Market update: 132 stocks hit fresh 52-week high on BSE; Tech Mahindra, SBI top Nifty losers  Money Control2 months ago
Business Standard

Cipla shines in gloomy pharma pack, biggest beneficiary of faster approvals

A low base in the US also means lower risks of price erosion, but as the company builds up its product pipeline expect earnings to improve Ujjval Jauhari Last Updated at November 22, 2017 12:02 IST An employee works at the reception area of Cipla at its ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less